Back
Santen Pharmaceutical Co., Ltd. Vs. Guardant Health, Inc. Industry Stock Comparison
Buy
51
SNPHY
Santen Pharmaceutical Co., Ltd.
Last Price:
$10.58
Seasonality Move:
-2.29%
Buy
60
GH
Guardant Health, Inc.
Last Price:
$103.00
Seasonality Move:
10.65%
Buy
51
Santen Pharmaceutical Co., Ltd. (SNPHY)
is a Buy
Is Santen Pharmaceutical Co., Ltd. a Buy, Sell or Hold?
-
The current Santen Pharmaceutical Co., Ltd. [SNPHY] share price is $10.58. The Score for SNPHY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
SNPHY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Guardant Health, Inc. (GH)
is a Buy
Is Guardant Health, Inc. a Buy, Sell or Hold?
-
The current Guardant Health, Inc. [GH] share price is $102.98. The Score for GH is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
GH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SNPHY Stock Price Chart
What is Santen Pharmaceutical Co., Ltd.'s stock price today?
-
The Santen Pharmaceutical Co., Ltd. share price today is $10.58Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNPHY is experiencing buying pressure, which is a positive indicator for future bullish movement.
GH Stock Price Chart
What is Guardant Health, Inc.'s stock price today?
-
The Guardant Health, Inc. share price today is $102.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GH is experiencing slight selling pressure.
SNPHY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.84 | Buy |
| Relative Strength Index (14 RSI): | 55.25 | Buy |
| Chaikin Money Flow: | 11266 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.02 - 10.44) | Buy |
| Bollinger Bands (100): | (9.98 - 10.94) | Buy |
GH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.51 | Buy |
| Relative Strength Index (14 RSI): | 56.88 | Buy |
| Chaikin Money Flow: | -91277 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.02 - 106.96) | Sell |
| Bollinger Bands (100): | (57.42 - 97.1) | Buy |
SNPHY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.4 | Buy |
| 20-day SMA: | 10.22 | Buy |
| 50-day SMA: | 10.12 | Buy |
| 200-day SMA: | 10.54 | Buy |
| 8-day EMA: | 8.61 | Buy |
| 20-day EMA: | 5.23 | Buy |
| 50-day EMA: | 2.53 | Buy |
| 200-day EMA: | 0.7 | Buy |
GH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 100.44 | Buy |
| 20-day SMA: | 102.68 | Buy |
| 50-day SMA: | 94.48 | Buy |
| 200-day SMA: | 61.25 | Buy |
| 8-day EMA: | 101.63 | Buy |
| 20-day EMA: | 101.15 | Buy |
| 50-day EMA: | 93.64 | Buy |
| 200-day EMA: | 67.25 | Buy |
Santen Pharmaceutical Co., Ltd. Earnings Growth & SNPHY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Guardant Health, Inc. Earnings Growth & GH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.36 per share.
Santen Pharmaceutical Co., Ltd. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Guardant Health, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||